Multiple Endocrine Neoplasia Type 1 is a hereditary tumour/cancer syndrome.
Multiple Endocrine Neoplasia Type 1 (MEN1) is a hereditary condition associated with an increased risk of tumours of the endocrine (hormoneproducing) glands.
These glands are located in different parts of the body and control the production of hormones that direct many body processes, including growth, digestion and sexual function.
MEN1 is caused by a fault (i.e., mutation) in the MEN1 gene. The gene provides instructions for producing a protein called menin which is known to play a role in keeping cells from growing and dividing too fast.
It is estimated that about one in 30,000 people have MEN1.
Hereditary tumours and cancers develop because of the presence of a faulty gene. Some genes function to protect us from tumour/cancer growth. When they are not working well, it causes an increased risk for tumours/cancers to grow. We refer to genes that are not working well as faulty genes.
Individuals who carry a faulty tumour/cancer gene(s) have a higher chance of developing certain tumours/cancers over their lifetime compared to the general population. The types of tumours/cancer that they may be at increased risk of will depend on the gene(s) involved.
If you have a faulty tumour/cancergene, you may be at increased risk of developing certain tumours/cancers. As genes are shared among family, other family members may have inherited the faulty gene and may be at increased risk of tumours/cancer too.
Genetic testing is offered to individuals where a hereditary cause of their personal and/or family history of tumours/cancer is suspected.
Genes contain the instructions that our body reads to carry out different functions. Genetic testing involves analysing your genes to understand if there are faults (i.e., mutations) that may increase the risk of tumours/cancer.
There are 3 types of results you may receive:
Subcribe to our mailing list to get the updates to your email inbox...